Feed aggregator

AstraZeneca divests global rights to Movantik

World Pharma News - Tue, 02/25/2020 - 13:00
AstraZeneca has agreed to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma (RedHill). Movantik is a peripherally acting mu-opioid receptor antagonist (PAMORA) indicated for the treatment of opioid-induced constipation (OIC).

Regular walnut consumption linked to health and longevity in women

World Pharma News - Tue, 02/25/2020 - 11:00
According to a new epidemiological study, women in their late 50s and early 60s who consumed at least two servings of walnuts per week had a greater likelihood of healthy aging compared to those who did not eat walnuts. After accounting for various factors that could impact health in older adults, such as education and physical activity, walnuts were the only nut associated with significantly better odds of healthy aging.

Moderna’s Coronavirus Vaccine Ready for Clinical Trials

Biospace news - Tue, 02/25/2020 - 02:00
As the number of cases and deaths continues to increase in China and around the world, Moderna shipped its first batch of mRNA-1273, a vaccine against the virus, for a planned Phase I clinical trial in the U.S.

Migraine Market: Biopharma Companies Working Toward Treatments

Biospace news - Tue, 02/25/2020 - 02:00
BioSpace takes a look at some of the investigational products that could, one day, provide relief for migraine sufferers.

Bicycle and Genentech Forge Immuno-Oncology Collaboration Worth up to $1.7 Billion

Biospace news - Tue, 02/25/2020 - 02:00
In its announcement, Bicycle did not identify the cancer targets it will focus on in its collaboration with Genentech.

RedHill Licenses AstraZeneca's Movantik for $68 Million

Biospace news - Tue, 02/25/2020 - 02:00
Under the license deal, RedHill is paying AstraZeneca $52.5 million up front with another non-contingent payment of $15 million 18 months after the deal closes.

FDA Accepts GSK's sNDA for Zejula as a First-Line Maintenance Treatment in Ovarian Cancer

Biospace news - Tue, 02/25/2020 - 02:00
The FDA is reviewing the sNDA under the Real-Time Oncology Review (RTOR) pilot program, which could speed up the process for potential approval.

Getting the Most Out of Negotiating a Job Offer

Biospace news - Tue, 02/25/2020 - 02:00
In order to play the “cat and mouse” game with poise, here’s a breakdown of the steps you’ll need to negotiate properly.

Top Companies in Genetown by Revenue

Biospace news - Tue, 02/25/2020 - 02:00
Genetown denotes the biopharmaceutical companies that are headquartered in Massachusetts.

Allecra's Exblifep Effective in Hospital-Based Urinary Tract Infections

Biospace news - Tue, 02/25/2020 - 02:00
Exblifep is a combination of a novel extended-spectrum beta-lactamase inhibitor, enmetazobactam, and the fourth-generation cephalosporin cefepime.

Mallinckrodt Files Chapter 11 for its Generics Business as it Reaches $1.6 Billion Opioid Settlement

Biospace news - Tue, 02/25/2020 - 02:00
In addition to the settlement and bankruptcy, Mallinckrodt entered into a debt refinancing agreement, including an $800 million loan that will be used to repay some outstanding debt and acquire some outstanding stocks.

Novartis Shares Fall Following Post-Marketing Concerns Over AMD Drug Beovu

Biospace news - Tue, 02/25/2020 - 02:00
The ASRS issued a note to its members about concerns regarding reports of vasculitis, an inflammation of the blood vessels and other complications that can lead to the loss of vision, as a potential side effect of treatment with Beovu.

Clover and GSK announce research collaboration to evaluate coronavirus (COVID-19) vaccine candidate with pandemic adjuvant system

World Pharma News - Mon, 02/24/2020 - 13:00
Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced today that it has entered into a research collaboration with GSK for its protein-based coronavirus vaccine candidate (COVID-19 S-Trimer).

SMi's 3rd Annual Pharmaceutical Microbiology East Coast

World Pharma News - Mon, 02/24/2020 - 11:00
29 - 30 April 2020, Boston, USA.
The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

Lundbeck's Vyepti Wins Approval for Preventative Treatment of Migraines

Biospace news - Mon, 02/24/2020 - 02:00
H. Lundbeck A/S is making a statement with its newly approved treatment for migraine, the first intravenous medication approved for the preventative treatment of migraine.

Esperion Wins FDA Approval for its Oral, Cholesterol-Lowering Drug

Biospace news - Mon, 02/24/2020 - 02:00
The company is planning for its drug to hit the streets by the end of March in order to provide a new option for patients with high cholesterol.

FDA Action Alert: GBT’s Oxbryta and BeiGene’s Brukinsa

Biospace news - Mon, 02/24/2020 - 02:00
Here’s a look at the two drugs that had dates this week but were approved early and are now on the market.

Report: Coronavirus Outbreak Could Cause Drug Shortages

Biospace news - Mon, 02/24/2020 - 02:00
The U.S. Food and Drug Administration is compiling a list of drugs that are at risk of shortage if the outbreak in China continues to worsen.

Clinical Catch-Up: February 17-21

Biospace news - Mon, 02/24/2020 - 02:00
Mid-February had a solid number of clinical trial announcements. Here’s a look.

Team Dynamics: 15 Life Sciences Organizations Leading the Way

Biospace news - Mon, 02/24/2020 - 02:00
The most recent BioSpace Ideal Employer Report revealed the impact of team dynamics on employees within life sciences organizations.